Inovio Pharmaceuticals (INO) 2.89 $INO
Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock
at The Street - Wed Apr 09, 9:01AM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma
PR Newswire - Tue Apr 08, 12:01PM CDT
The trading session on Monday, April 07, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,245.87, down 1.02% and the NASDAQ Composite closed at 4,079.75, down 1.16%. The S&P 500 finished the session 1.08% lower at 1,845.04. The losses were broad based as nine out of ten sectors posted losses. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Mallinckrodt PLC (NYSE: MNK), American Eagle Outfitters Inc. (NYSE: AEO), Blackstone Group L.P. (NYSE: BX) and Inovio Pharmaceuticals Inc. (NYSE MKT: INO). Free technical research on MNK, AEO, BX and INO can be downloaded upon signing up at:
5 Biotechs With Prostate Cancer Treatments Worth Watching
George Budwell, The Motley Fool - Motley Fool - Sat Apr 05, 4:30PM CDT
In the United States, prostate cancer is now the most common type of malignancy detected in men. Even more concerning is that prostate cancer has crept up to the second-leading cause of cancer-specific deaths among men in the U.S., according to...
Use Options For A Chance To Buy INO At A 42% Discount
at The Street - Fri Apr 04, 10:50AM CDT
Looking back to 36 days ago, Inovio Pharmaceuticals priced a 18,966,000 share secondary stock offering at $2.90 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
Healthcare Companies Announce Awards, Partnerships, Milestone Payments, and Conference Schedules - Analyst Notes on Inovio, LifePoint, Mallinckrodt, Ligand, and Theravance
PR Newswire - Wed Apr 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Inovio Pharmaceuticals, Inc. (NYSEMKT: INO), LifePoint Hospitals Inc. (NASDAQ: LPNT), Mallinckrodt plc (NYSE: MNK), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), and Theravance Inc. (NASDAQ: THRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
PR Newswire - Tue Apr 01, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. He will report to Inovio's Chief Operating Officer Dr. Niranjan Sardesai.
Jim Cramer's Top Stock Picks: KMX FINL INO BAC
at The Street - Sat Mar 29, 5:00AM CDT
Bank of America is the financial stock to own if next week's jobs number is better than expected while Finish Line is bucking the retail trend and deserves to be higher, Cramer says.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Mar 28, 7:21PM CDT
Cramer says the market needs both a China stimulus plan and positive U.S. employment numbers to sustain any gains.
Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 8:46AM CDT
Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as the company saw its shares shoot up nearly 13% on the day.
3 Biotech Stocks Under $10 to Trade for Breakouts
at The Street - Fri Mar 28, 5:00AM CDT
Keep these under-$10 biotech stocks on your radar.
Inovio Pharmaceuticals (INO) Surges on Heavy Volume
at The Street - Thu Mar 27, 3:35PM CDT
Inovio Pharmaceuticals (INO) closed Thursday higher on heavier-than-normal trading volume.
Trade-Ideas: Inovio Pharmaceuticals (INO) Is Today's "Barbarian At The Gate" Stock
at The Street - Thu Mar 27, 2:21PM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Today's Dead Cat Bounce Stock: Inovio Pharmaceuticals (INO)
at The Street - Wed Mar 26, 8:46AM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014
PR Newswire - Wed Mar 26, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the global industry as judged by a panel of global biotech industry stakeholders.
Equities Updates, Most Active -- Research on Inovio Pharma, Oi S.A., GameStop, and Banco Bradesco
PR Newswire - Wed Mar 19, 7:00AM CDT
The trading session on Tuesday, March 18, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,336.19, up 0.55% and the NASDAQ Composite closed at 4,333.31, up 1.25%. The S&P 500 finished the session 0.72% higher at 1,872.25. The gains were broad based as nine of ten sectors ended the session in positive. During the session healthy gains in the Information Technology, Health Care, and Energy sectors positively impacted the broader market. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Inovio Pharmaceuticals Inc. (AMEX: INO), Oi S.A. (NYSE: OIBR), GameStop Corp (NYSE: GME), and Banco Bradesco S.A. (NYSE: BBD). Free technical research on INO, OIBR, GME and BBD can be downloaded upon signing up at:
Key Takeaways from Inovio Pharmaceuticals, Inc. Earnings Report
George Budwell, The Motley Fool - Motley Fool - Tue Mar 18, 5:30PM CDT
Most developmental stage biotechs eventually face a 'make or break' moment during the course of their life-cycle. Generally speaking, these key events oft-center around clinical trial data that either validate or sink the company's experimental...
Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results
PR Newswire - Mon Mar 17, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013.
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014
PR Newswire - Wed Mar 12, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its fourth quarter and year end 2013 financial results on Monday, March 17, 2014 at 8:30 a.m. ET. Management will provide an update on the company, discuss fourth quarter and year end results, and discuss expectations for 2014.
Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing
PR Newswire - Tue Mar 04, 8:49AM CST
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"
, today closed its previously announced underwritten public offering of 21,810,900 shares of the Company's common stock, including 2,844,900 shares of common stock issued pursuant to the underwriter's exercise of its overallotment option, at the public offering price of $2.90 per share. The gross proceeds of this offering were approximately $63.3 million. Net proceeds to the Company, after deducting the underwriter's discounts and commission and other estimated offering expenses payable by the Company, were approximately $59.2 million.
Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock
at The Street - Wed Apr 09, 9:01AM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma
PR Newswire - Tue Apr 08, 12:01PM CDT
The trading session on Monday, April 07, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,245.87, down 1.02% and the NASDAQ Composite closed at 4,079.75, down 1.16%. The S&P 500 finished the session 1.08% lower at 1,845.04. The losses were broad based as nine out of ten sectors posted losses. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Mallinckrodt PLC (NYSE: MNK), American Eagle Outfitters Inc. (NYSE: AEO), Blackstone Group L.P. (NYSE: BX) and Inovio Pharmaceuticals Inc. (NYSE MKT: INO). Free technical research on MNK, AEO, BX and INO can be downloaded upon signing up at:
5 Biotechs With Prostate Cancer Treatments Worth Watching
George Budwell, The Motley Fool - Motley Fool - Sat Apr 05, 4:30PM CDT
In the United States, prostate cancer is now the most common type of malignancy detected in men. Even more concerning is that prostate cancer has crept up to the second-leading cause of cancer-specific deaths among men in the U.S., according to...
Use Options For A Chance To Buy INO At A 42% Discount
at The Street - Fri Apr 04, 10:50AM CDT
Looking back to 36 days ago, Inovio Pharmaceuticals priced a 18,966,000 share secondary stock offering at $2.90 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
Healthcare Companies Announce Awards, Partnerships, Milestone Payments, and Conference Schedules - Analyst Notes on Inovio, LifePoint, Mallinckrodt, Ligand, and Theravance
PR Newswire - Wed Apr 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Inovio Pharmaceuticals, Inc. (NYSEMKT: INO), LifePoint Hospitals Inc. (NASDAQ: LPNT), Mallinckrodt plc (NYSE: MNK), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), and Theravance Inc. (NASDAQ: THRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
PR Newswire - Tue Apr 01, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. He will report to Inovio's Chief Operating Officer Dr. Niranjan Sardesai.
Jim Cramer's Top Stock Picks: KMX FINL INO BAC
at The Street - Sat Mar 29, 5:00AM CDT
Bank of America is the financial stock to own if next week's jobs number is better than expected while Finish Line is bucking the retail trend and deserves to be higher, Cramer says.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Mar 28, 7:21PM CDT
Cramer says the market needs both a China stimulus plan and positive U.S. employment numbers to sustain any gains.
Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 8:46AM CDT
Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as the company saw its shares shoot up nearly 13% on the day.
3 Biotech Stocks Under $10 to Trade for Breakouts
at The Street - Fri Mar 28, 5:00AM CDT
Keep these under-$10 biotech stocks on your radar.
Inovio Pharmaceuticals (INO) Surges on Heavy Volume
at The Street - Thu Mar 27, 3:35PM CDT
Inovio Pharmaceuticals (INO) closed Thursday higher on heavier-than-normal trading volume.
Trade-Ideas: Inovio Pharmaceuticals (INO) Is Today's "Barbarian At The Gate" Stock
at The Street - Thu Mar 27, 2:21PM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Today's Dead Cat Bounce Stock: Inovio Pharmaceuticals (INO)
at The Street - Wed Mar 26, 8:46AM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014
PR Newswire - Wed Mar 26, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the global industry as judged by a panel of global biotech industry stakeholders.
Equities Updates, Most Active -- Research on Inovio Pharma, Oi S.A., GameStop, and Banco Bradesco
PR Newswire - Wed Mar 19, 7:00AM CDT
The trading session on Tuesday, March 18, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,336.19, up 0.55% and the NASDAQ Composite closed at 4,333.31, up 1.25%. The S&P 500 finished the session 0.72% higher at 1,872.25. The gains were broad based as nine of ten sectors ended the session in positive. During the session healthy gains in the Information Technology, Health Care, and Energy sectors positively impacted the broader market. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Inovio Pharmaceuticals Inc. (AMEX: INO), Oi S.A. (NYSE: OIBR), GameStop Corp (NYSE: GME), and Banco Bradesco S.A. (NYSE: BBD). Free technical research on INO, OIBR, GME and BBD can be downloaded upon signing up at:
Key Takeaways from Inovio Pharmaceuticals, Inc. Earnings Report
George Budwell, The Motley Fool - Motley Fool - Tue Mar 18, 5:30PM CDT
Most developmental stage biotechs eventually face a 'make or break' moment during the course of their life-cycle. Generally speaking, these key events oft-center around clinical trial data that either validate or sink the company's experimental...
Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results
PR Newswire - Mon Mar 17, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013.
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014
PR Newswire - Wed Mar 12, 3:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its fourth quarter and year end 2013 financial results on Monday, March 17, 2014 at 8:30 a.m. ET. Management will provide an update on the company, discuss fourth quarter and year end results, and discuss expectations for 2014.
Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing
PR Newswire - Tue Mar 04, 8:49AM CST
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"
, today closed its previously announced underwritten public offering of 21,810,900 shares of the Company's common stock, including 2,844,900 shares of common stock issued pursuant to the underwriter's exercise of its overallotment option, at the public offering price of $2.90 per share. The gross proceeds of this offering were approximately $63.3 million. Net proceeds to the Company, after deducting the underwriter's discounts and commission and other estimated offering expenses payable by the Company, were approximately $59.2 million. 
